Click on image to view larger version.

Figure 5 Serial Changes in MCP-1 and Subsequent Mortality

Nelson-Aalen cumulative hazard estimates in subgroups defined by monocyte chemoattractant protein (MCP)-1 levels at baseline and at 4 months. High MCP-1 levels are defined as >238 pg/ml and low as 238 pg/ml. Each curve represents a subgroup defined by baseline/4 month MCP-1 levels. Events before 4 months were censored. Patients with MCP-1 levels >238 pg/ml at both baseline and 4 months had significantly higher mortality rates compared with the other groups.